<VariationArchive VariationID="1699419" VariationName="NM_000405.5(GM2A):c.209del (p.Gly70fs)" VariationType="Deletion" Accession="VCV001699419" Version="3" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-23" DateCreated="2022-08-08" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1691793" VariationID="1699419">
      <GeneList>
        <Gene Symbol="GM2A" FullName="ganglioside GM2 activator" GeneID="2760" HGNC_ID="HGNC:4367" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q33.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="151253185" stop="151270440" display_start="151253185" display_stop="151270440" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="150632612" stop="150649954" display_start="150632612" display_stop="150649954" Strand="+" />
          </Location>
          <OMIM>613109</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000405.5(GM2A):c.209del (p.Gly70fs)</Name>
      <CanonicalSPDI>NC_000005.10:151259879:GGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q33.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="151259880" stop="151259880" display_start="151259880" display_stop="151259880" variantLength="1" positionVCF="151259879" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="150639441" stop="150639441" display_start="150639441" display_stop="150639441" variantLength="1" positionVCF="150639440" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>G70fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.151259882del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.151259882del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.150639443del" Assembly="GRCh37">
            <Expression>NC_000005.9:g.150639443del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009059.1" sequenceAccession="NG_009059" sequenceVersion="1" change="g.11831del">
            <Expression>NG_009059.1:g.11831del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000405.5" sequenceAccession="NM_000405" sequenceVersion="5" change="c.209del" MANESelect="true">
            <Expression>NM_000405.5:c.209del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000396.2" sequenceAccession="NP_000396" sequenceVersion="2" change="p.Gly70fs">
            <Expression>NP_000396.2:p.Gly70fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001167607.3" sequenceAccession="NM_001167607" sequenceVersion="3" change="c.209del">
            <Expression>NM_001167607.3:c.209del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001161079.1" sequenceAccession="NP_001161079" sequenceVersion="1" change="p.Gly70fs">
            <Expression>NP_001161079.1:p.Gly70fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2114032531" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000405.5(GM2A):c.209del (p.Gly70fs) AND Tay-Sachs disease, variant AB" Accession="RCV002273276" Version="3">
        <ClassifiedConditionList TraitSetID="105">
          <ClassifiedCondition DB="MedGen" ID="C0268275">Tay-Sachs disease, variant AB</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-02-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-02-02" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-08-08" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10364519</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24767253</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26082327</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28417072</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="105" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5205" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Gm2-gangliosidosis, ab variant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Tay-Sachs disease, variant AB</ElementValue>
                <XRef ID="Gm2-gangliosidosis%2C+ab+variant/8491" DB="Genetic Alliance" />
                <XRef ID="71253000" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Acute infantile GM2 activator deficiency is a neurodegenerative disorder in which infants, who are generally normal at birth, have progressive weakness and slowing of developmental progress between ages four and 12 months. An ensuing developmental plateau is followed by progressively rapid developmental regression. By the second year of life decerebrate posturing, difficulty in swallowing, and worsening seizures lead to an unresponsive vegetative state. Death usually occurs between ages two and three years.</Attribute>
                <XRef ID="NBK583219" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17406" />
                <XRef ID="17406" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">36007105</ID>
                <ID Source="BookShelf">NBK583219</ID>
              </Citation>
              <XRef ID="309246" DB="Orphanet" />
              <XRef ID="C0268275" DB="MedGen" />
              <XRef ID="MONDO:0010099" DB="MONDO" />
              <XRef Type="MIM" ID="272750" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5003853" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2022-08-08">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_000405_4_GM2A_c_209delG" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002558047" DateUpdated="2024-07-23" DateCreated="2022-08-08" Type="SCV" Version="2" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10364519</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24767253</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26082327</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28417072</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with GM2-gangliosidosis, AB variant (MIM# 272750). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251- This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0703 - Other NMD-predicted variants comparable to the one identified in this case have moderate previous evidence for pathogenicity. Some NMD-predicted variants have been reported in patients with GM2A-related disorders (PMID: 10364519, 24767253, 26082327, 28417072). (SP) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1205 - This variant has been shown to be maternally inherited. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GM2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_15179</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000405.4:c.209delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="272750" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_32</SubmissionName>
          <SubmissionName>submission_45</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5003853" TraitType="Disease" MappingType="XRef" MappingValue="272750" MappingRef="OMIM">
        <MedGen CUI="C0268275" Name="Tay-Sachs disease, variant AB" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

